Bausch Health Cos Revenue 2010-2024 | BHC

Bausch Health Cos revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Bausch Health Cos Annual Revenue
(Millions of US $)
2023 $8,757
2022 $8,124
2021 $8,434
2020 $8,027
2019 $8,601
2018 $8,380
2017 $8,724
2016 $9,674
2015 $10,447
2014 $8,206
2013 $5,770
2012 $3,480
2011 $2,427
2010 $1,181
2009 $820
Bausch Health Cos Quarterly Revenue
(Millions of US $)
2024-09-30 $2,510
2024-06-30 $2,403
2024-03-31 $2,153
2023-12-31 $2,408
2023-09-30 $2,238
2023-06-30 $2,167
2023-03-31 $1,944
2022-12-31 $2,193
2022-09-30 $2,046
2022-06-30 $1,967
2022-03-31 $1,918
2021-12-31 $2,196
2021-09-30 $2,111
2021-06-30 $2,100
2021-03-31 $2,027
2020-12-31 $2,213
2020-09-30 $2,138
2020-06-30 $1,664
2020-03-31 $2,012
2019-12-31 $2,224
2019-09-30 $2,209
2019-06-30 $2,152
2019-03-31 $2,016
2018-12-31 $2,121
2018-09-30 $2,136
2018-06-30 $2,128
2018-03-31 $1,995
2017-12-31 $2,163
2017-09-30 $2,219
2017-06-30 $2,233
2017-03-31 $2,109
2016-12-31 $2,403
2016-09-30 $2,479
2016-06-30 $2,420
2016-03-31 $2,372
2015-12-31 $2,758
2015-09-30 $2,787
2015-06-30 $2,732
2015-03-31 $2,170
2014-12-31 $2,223
2014-09-30 $2,056
2014-06-30 $2,041
2014-03-31 $1,886
2013-12-31 $2,064
2013-09-30 $1,542
2013-06-30 $1,096
2013-03-31 $1,068
2012-12-31 $920
2012-09-30 $884
2012-06-30 $820
2012-03-31 $856
2011-12-31 $652
2011-09-30 $601
2011-06-30 $609
2011-03-31 $565
2010-12-31 $515
2010-09-30 $208
2010-06-30 $239
2010-03-31 $220
2009-12-31 $241
2009-09-30 $213
2009-06-30 $194
2009-03-31 $173
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00